# Emerging Infections Sentinel Networks (EISN) Research

Source: https://welltoldgrants.com/grants/rfa-ck-22-003-emerging-infections-sentinel-networks-eisn-research/  
Official notice: https://www.grants.gov/search-results-detail/334472

> Centers for Disease Control and Prevention - ERA offered grants of up to $300,000 (at least $200,000) to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. It expected to make one award worth $1.3 million in total. Applications closed on November 1, 2021.

| Field | Value |
|---|---|
| Opportunity number | RFA-CK-22-003 |
| Agency | Centers for Disease Control and Prevention - ERA |
| Status | Forecast |
| Deadline | November 1, 2021 |
| Award ceiling | $300,000 |
| Award floor | $200,000 |
| Expected awards | 1 |
| Total funding | $1.3 million |
| Cost sharing | not required |
| Assistance Listings | 93.860 |

## Who can apply

- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)

Hospitals and Medical Centers may also apply

## What the grant funds

The purpose of this Notice of Funding Opportunity (NOFO) is to provide a funding mechanism for Emerging Infections Sentinel Networks (EISN) research activities, specifically within a network of emergency departments (EDs). The EISN program will assist in operating emergency department provider-based sentinel networks. These networks will contribute to surveillance for emerging infectious diseases (EID), such as those caused by agents of bioterrorism, pathogens of pandemic potential, drug-resistant, foodborne or waterborne microorganisms, and vaccine-preventable or potentially vaccine-preventable diseases (e.g., Bacillus anthracis. new coronaviruses, Clostridium difficile, carbapenem-resistant Enterobacteriaceae, viral hepatitis and respiratory viruses of epidemic or pandemic potential, tuberculosis, sexually transmitted diseases), and help inform operational public health and healthcare decisions during public health emergencies (e.g., assessment of rapid screening and triage protocols during surge of infectious disease cases presenting for clinical care; assessment of clinical characteristics and development of rapid epidemiologic studies during emergencies to improve the understanding of the clinical characteristics, impacts and outcomes of new and emerging diseases), help better understand and address the disproportionate impact of EIDs on underserved and disadvantaged populations, and enhance information exchange.

## Questions people ask

### Is RFA-CK-22-003 still open?

No. It closed on November 1, 2021.

### Who can apply for Emerging Infections Sentinel Networks (EISN) Research?

Centers for Disease Control and Prevention - ERA accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Emerging Infections Sentinel Networks (EISN) Research?

Closed November 1, 2021. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $300,000 each. About $1.3 million in total for one award.

### Who has won Emerging Infections Sentinel Networks grants before?

The largest recipients over five fiscal years were University of California, Los Angeles, Olive View/UCLA Education and Research Institute, Inc., The International Society of Travel Medicine, Incorporated. The program made 5 awards worth $25.0 million in that time.